IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium

Journal of the American Society of Nephrology

Volumn 25, Issue 5, 2014, Pages 967-977

  Xu, Ming Jiang ^a,b   Feng, Dechun ^a   Wang, Hua ^a   Guan, Youfei ^b   Yan, Xiaoqiang ^c   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c Generon Corporation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 22R1; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE B; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 22; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; INTERLEUKIN-22 RECEPTOR; RECOMBINANT PROTEIN; STAT3 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; ADENOVIRIDAE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRUSH BORDER; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; GENE OVEREXPRESSION; GENE TARGETING; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SURVIVAL RATE; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE MOUSE; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; UROTHELIUM;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; GENE TARGETING; INTERLEUKINS; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN; RECOMBINANT PROTEINS; REPERFUSION INJURY; STAT3 TRANSCRIPTION FACTOR; UROTHELIUM;

EID: 84902109613     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060611     Document Type: Article

References (28)

1. Rutz S, Ouyang W: Regulation of interleukin-10 and interleukin-22 expression in T helper cells. Curr Opin Immunol 23: 605-612, 2011
2. Witte E, Witte K, Warszawska K, Sabat R, Wolk K: Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 21: 365-379, 2010
3. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S: Identification of the functional interleukin-22 (IL-22) receptor complex: The IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.J Biol Chem276: 2725-2732, 2001
4. Wolk K, Witte E,Witte K,Warszawska K, Sabat R: Biology of interleukin-22. Semin Immunopathol 32: 17-31, 2010
5. Mühl H, Scheiermann P, Bachmann M, Härdle L, Heinrichs A, Pfeilschifter J: IL-22 in tissue-protective therapy. Br J Pharmacol 169: 761-771, 2013
6. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011
7. Lameire N, Van BiesenW, Vanholder R: The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2: 364-377, 2006
8. Waikar SS, Liu KD, Chertow GM: Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 3: 844-861, 2008
9. Garcia-Tsao G, Parikh CR, Viola A: Acute kidney injury in cirrhosis. Hepatology 48: 2064-2077, 2008
10. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O: Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial.Gastroenterology 119: 1637-1648, 2000
11. Johnson KJ, Weinberg JM: Postischemic renal injury due to oxygen radicals. Curr Opin Nephrol Hypertens 2: 625-635, 1993
12. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003
13. Bonventre JV, Zuk A: Ischemic acute renal failure: An inflammatory disease? Kidney Int 66: 480-485, 2004
14. Abuelo JG: Normotensive ischemic acute renal failure. N Engl J Med 357: 797-805, 2007
15. Miura M, Fu X, Zhang QW, Remick DG, Fairchild RL: Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 159: 2137-2145, 2001
16. Singbartl K, Ley K: Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit CareMed 28: 2507-2514, 2000
17. Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 80: 29-40, 2011
18. Kaushal GP, Basnakian AG, Shah SV: Apoptotic pathways in ischemic acute renal failure. Kidney Int 66: 500-506, 2004
19. Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS, Gao B: Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56: 1150-1159, 2012
20. Feng D, Kong X, Weng H, Park O, Wang H, Dooley S, Gershwin ME, Gao B: Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology 143: 188-198, 2012
21. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC: Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct fromIL-10. J Biol Chem277: 33676-33682, 2002
22. Mitra A, Raychaudhuri SK, Raychaudhuri SP: IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade. Cytokine 60: 38-42, 2012
23. Chuang PY,He JC: JAK/STAT signaling in renal diseases. Kidney Int 78: 231-234, 2010
24. Yang N, Luo M, Li R, Huang Y, Zhang R, Wu Q, Wang F, Li Y, Yu X: Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrol Dial Transplant 23: 91-100, 2008
25. Ponnusamy M, Pang M, Annamaraju PK, Zhang Z, Gong R, Chin YE, Zhuang S: Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways. Am J Physiol Renal Physiol 297: F1361-F1370, 2009
26. Wang J,Ouyang C, Chen X, Fu B, Lu Y, Hong Q: Effect of Jak2 kinase inhibition on Stat1 and Stat3 activation and apoptosis of tubular epithelial cells induced by ATP depletion/recovery. J Nephrol 21: 919-923, 2008
27. Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, Ki SH, Yoo SH, Dooley S, Wang FS, Young HA, Gao B: In vivo consequences of liverspecific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 54: 252-261, 2011
28. Nomura A, Nishikawa K, Yuzawa Y, Okada H, Okada N, Morgan BP, Piddlesden SJ, Nadai M, Hasegawa T, Matsuo S: Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest 96: 2348-2356, 1995